Dupuytren Research Group Inc
Data sourced from IRS 990 public filings
Dupuytren Research Group Inc Our Mission is to do whatever is needed to develop and test preventive treatments for Dupuytren disease and related conditions. Our core effort focuses on answering the greatest need in Dupuytren treatment: developing a Dupuytren blood test.
Dupuytren Research Group Inc has received 17 grants from 11 known foundation funders. Revenue increased from $261,908 in 2023 to $287,301 in 2024. Most recent reported revenue: $287,301.
Annual Revenue
$287,301
Known Funders
11
Grants Received
17
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $287,301 | $168,766 | $847,586 |
| 2023 | $261,908 | $166,423 | $719,801 |
| 2022 | $219,098 | $187,358 | $625,020 |
| 2021 | $197,762 | $225,604 | $595,262 |
| 2020 | $174,941 | $270,745 | $624,946 |
| 2019 | $399,852 | $142,918 | $717,384 |
| 2018 | $197,863 | $120,489 | $391,131 |
| 2017 | $222,006 | $108,760 | $319,734 |
Top Funders
WORCESTER, MA
WELLESLEY, MA
WELLESLEY, MA
WELLESLEY, MA
LAS VEGAS, NV
SLEEPY HOLLOW, NY
Wilmington, DE
Wilmington, DE
Wilmington, DE
Wilmington, DE
Showing top 10 of 11 funders.
Key Personnel
From 2024 IRS 990 filing
Peter Geimer
Director
Gary Pess MD
Director
Laura Holmes Jost
Director
Stuart Landow
Director
Keither Raskin MD
Director
Tom Hardart
Director
DR Charles Eaton
Executive Director
Frequently Asked Questions
Other Nonprofits in Florida
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.